Chargement en cours...
Are We Ready for the 10% Solution?
The limitations of the Response Evaluation Criteria in Solid Tumors (RECIST) for the assessment of molecularly targeted agents have been increasingly recognized with the advance of new therapies. The current study and others focusing on vascular endothelial growth factor-pathway inhibitors in advanc...
Enregistré dans:
| Auteurs principaux: | , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
AlphaMed Press
2014
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4012974/ https://ncbi.nlm.nih.gov/pubmed/24755462 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2014-0126 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|